Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
Explorative study, which evaluates the effect of Camrelizumab combined with albumin-bound paclitaxel and platinum in neoadjuvant treatment of resectable non-small-cell lung carcinoma.
Epistemonikos ID: 1bca0667c988f111f3e92cdc4a3d8b1ef85eac3f
First added on: Dec 20, 2022